Development of a multimarker assay for early detection of ovarian cancer. - Wikidata - thesis-toulmin - TriplyDB

Development of a multimarker assay for early detection of ovarian cancer.

Development of a multimarker assay for early detection of ovarian cancer.

http://www.wikidata.org/entity/Q33813724

about

In 2014, can we do better than CA125 in the early detection of ovarian cancer?The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice.Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.Serum biomarker panels for the detection of pancreatic cancer A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites.Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.Ovarian cancer biomarkers for molecular biosensors and translational medicine.Down-regulated aquaporin 5 inhibits proliferation and migration of human epithelial ovarian cancer 3AO cells Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic.DR6 as a diagnostic and predictive biomarker in adult sarcoma.Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers Nanotexture Optimization by Oxygen Plasma of Mesoporous Silica Thin Film for Enrichment of Low Molecular Weight Peptides Captured from Human Serum.Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data.Protein biomarkers of ovarian cancer: the forest and the trees A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.Multiplexed volumetric bar-chart chip for point-of-care diagnostics Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors.NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Urinary protein biomarkers in the early detection of lung cancer.Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis Autoantibody signature for the serologic detection of ovarian cancer Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.Ovarian Cancer Tests and Treatment.The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study Functional biomarkers of depression: diagnosis, treatment, and pathophysiology Tag-femtosecond laser-induced breakdown spectroscopy for the sensitive detection of cancer antigen 125 in blood plasma.

P2860

Q26825152-2CBF6CFC-2A03-4AA2-A365-BA86554F53C9 Q26992102-10813B02-15B6-4188-8230-F78FCC2BF2BE Q30253028-CF76F5EE-5919-4298-A067-146A899630C8 Q30382105-D8F20008-8ED0-4031-ADEC-A602A8BE2387 Q30414345-7A9B120C-1976-4437-9709-CBA5F33C7CCF Q30418500-5C3B4165-71DB-4E71-90C3-E57B2C422921 Q30458233-94884ECD-C68A-469C-9B42-3C92F1E547F5 Q30490448-5828885B-0463-4AC2-9D57-17ABA7A5354F Q30499531-BA391013-716D-428D-AB9A-30C80D752C7C Q30511822-0512049B-9156-480E-AFE4-3321B96B5CBC Q33733786-1395B940-5710-4FF6-99BB-AD409B88D3A8 Q33862961-8A27B43E-399B-440C-AE8D-F4B98DB4DAAE Q33944027-5C2DC2E3-B2C0-491E-AC27-106C48699023 Q33946367-DB9010B5-A579-4EBA-A1CA-857CE72E057C Q33946840-D6219286-F832-478B-B6E1-D7E3AEB24072 Q34150097-B0B6F83F-CFDD-47DF-B895-8E89CD5FE8F7 Q34185010-D4EAA3B0-A39E-4E81-AFC0-EE8DFF811D0B Q34190938-0E2D7EE9-D9BB-4FFF-9C28-DC373ABD399E Q34261836-3868D059-8ACD-4F6E-BB2F-13872AC82E4E Q34308808-F5610DF4-071A-4F23-B385-7ED173446099 Q34412873-53D18250-BFAD-481F-B6F3-B367B9DDF08C Q34416375-D8CFC4D9-262E-433E-B958-08408448A8BE Q34555631-ED4A1DD0-6EC0-4E78-8056-3AC6A0D72A02 Q34634143-0B0E9108-AF4A-4D58-9D72-D301D36D21C0 Q34646749-26D6F57B-E438-4C89-8CC3-BCAE27A39A8C Q34700249-8B370576-AE48-4EAA-A227-E4B993287302 Q34738849-779A431C-590F-4635-A4B9-C30A80E7A7E8 Q34749242-9E20878C-018E-4B30-97C5-C3DB8BB3E41A Q34898683-859FE1D6-5CFD-4616-8821-071043DE748F Q35021181-FE3B01A4-10CD-4ACC-8831-9AC427A398B1 Q35044516-0CE12AD7-3187-49C4-B1E8-EA944A81C8DD Q35084936-2D5E48E8-174C-467D-8662-32CC5F005882 Q35100846-69AAC550-1E95-4044-90DE-6B008BB35187 Q35152701-3CAE7E99-D732-46BD-B749-DE27EB572BDE Q35160147-8B9BD327-5138-4726-9FBB-EB70F50977BD Q35185640-576258BF-B647-4237-8336-64892AC83803 Q35186832-CB44EF84-D423-4F6B-9458-4E68048FCAF2 Q35208879-E9B46022-401A-4784-B380-83E8C83C025B Q35356872-A9FE3166-B218-41D4-8F4C-8F4118794A04 Q35541160-CCB30832-C093-4C1A-A7A9-DF58071B1193

P2860

Development of a multimarker assay for early detection of ovarian cancer.

http://www.wikidata.org/entity/Q33813724

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of a multimarker assay for early detection of ovarian cancer.

@ast

Development of a multimarker assay for early detection of ovarian cancer.

@en

type

label

Development of a multimarker assay for early detection of ovarian cancer.

@ast

Development of a multimarker assay for early detection of ovarian cancer.

@en

prefLabel

Development of a multimarker assay for early detection of ovarian cancer.

@ast

Development of a multimarker assay for early detection of ovarian cancer.

@en

P1433

Q33813724-7B049D74-471A-4A42-B15E-D08F91C961DB

P1476

Q33813724-C77F14AD-7F83-4948-97F5-F814F15966F5

P2093

Q33813724-1E10C669-EB4A-4C8E-BB52-2F9B4DC58C89

Q33813724-2743DA86-2097-45B5-B628-D12AA49822C4

Q33813724-3EB11501-3798-4AF4-8DE0-205F8F92D7CC

Q33813724-5C586600-25DC-41E2-B0A4-A956CED7E7E6

Q33813724-95C4BA7D-1450-4F0C-845A-3843BDE81503

Q33813724-BC0F225E-02A8-4706-8C0E-CAAC46256421

Q33813724-C3C205E3-E22A-4C8F-BA50-3EE363E62E25

Q33813724-CCDAAF3D-7F3B-4B58-B142-879F739BD595

Q33813724-CDB438AA-5DC1-4BD0-9E88-61617D2901E5

Q33813724-D2880292-A67A-4503-B7D4-AE4A58A28130

P2860

Q33813724-0262071A-F2FA-483E-8BEB-293B13B015F3

Q33813724-0B205AD7-B17E-4EE4-A5A6-5D8591EFAF1B

Q33813724-0EBC97E0-5563-4CF5-B0E6-2BD7EE9A2960

Q33813724-0EEDA718-0D9B-48CD-82F5-B41042D06106

Q33813724-121C536C-CD75-49B6-AC16-7CF72E0585CE

Q33813724-124464F0-FDD8-4818-8386-F3CB423939F5

Q33813724-12C030A3-03B9-4DB9-8A53-BD83B1834E5F

Q33813724-1A70885E-3B3E-4759-B608-3DF08F51A004

Q33813724-1FC36774-C4EB-4BD5-80BE-5EB00E813A56

Q33813724-27143A9D-98B3-4A35-8B14-3B6E71EB7A29

P304

Q33813724-E31E07CE-0CC3-476B-AD2D-78903E21C0E7

P31

Q33813724-CA4FEFBA-54A6-4297-8CFB-4A9CF05CCDCD

P356

Q33813724-6AE09C27-1D3F-4A29-8CE6-34B003EB5FE8

P407

Q33813724-3C7DA9A5-781B-4EEA-A419-AD59D409ED53

P433

Q33813724-CEA8AE72-2A01-49FA-AF35-A2DD637AF2E5

P478

Q33813724-E1F66E6F-A3BB-48AB-A7AB-0C4415F7E3A0

P50

Q33813724-06C37355-35F2-42F2-9C6B-16B3D13212E3

Q33813724-4F5FBCE7-8054-4381-8E84-73DBC018E899

Q33813724-6D13FC0E-8A2B-4B6B-8261-A6531981D29E

P577

Q33813724-D6D8533F-F5B7-490A-9F96-666317C77339

P698

Q33813724-92D915C4-C065-481A-A589-395BD91F11DA

P921

Q33813724-2B3557D3-4438-4C3C-AF16-B1CCAC4B5181

P932

Q33813724-B1F1819B-A876-432B-8E06-484C0110E6D6

P356

JCO.2008.19.2484

P1433

Journal of Clinical Oncology

P1476

Development of a multimarker assay for early detection of ovarian cancer.

@en

P2093

Aleksey Lomakin

http://www.w3.org/2001/XMLSchema#string

Andrew Godwin

http://www.w3.org/2001/XMLSchema#string

Anna E Lokshin

http://www.w3.org/2001/XMLSchema#string

Brian Nolen

http://www.w3.org/2001/XMLSchema#string

Donna Badgwell

http://www.w3.org/2001/XMLSchema#string

Elieser Gorelik

http://www.w3.org/2001/XMLSchema#string

Ian Jacobs

http://www.w3.org/2001/XMLSchema#string

Jeffrey Marks

http://www.w3.org/2001/XMLSchema#string

Karen Lu

http://www.w3.org/2001/XMLSchema#string

Steven Skates

http://www.w3.org/2001/XMLSchema#string

P2860

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

Cancer statistics, 2008

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

Serum tumor markers

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

Progress and challenges in screening for early detection of ovarian cancer.

Serum protein markers for early detection of ovarian cancer

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

Gynecological cancers.

CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.

P304

2159-2166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.19.2484

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Francesmary Modugno

P577

2010-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20368574

http://www.w3.org/2001/XMLSchema#string

P921

P932

2860434

http://www.w3.org/2001/XMLSchema#string